Rapidly progressive glomerulonephritis epidemiology and demographics
Rapidly progressive glomerulonephritis Microchapters |
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Rapidly progressive glomerulonephritis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis epidemiology and demographics |
FDA on Rapidly progressive glomerulonephritis epidemiology and demographics |
CDC on Rapidly progressive glomerulonephritis epidemiology and demographics |
Rapidly progressive glomerulonephritis epidemiology and demographics in the news |
Blogs on Rapidly progressive glomerulonephritis epidemiology and demographics |
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Epidemiology and demographics
Incidence
- The incidence of rapidly progressive glomerulonephritis is around 1 per million individuals per year.[1]
- In the United Kingdom, the incidence of rapidly progressive glomerulonephritis is estimated to be 2 per 100,000 individuals.
- In Sweden, the incidence of rapidly progressive glomerulonephritis is estimated to be 1 case per 100,000 persons.
Age
- The prevalence of rapidly progressive glomerulonephritis increases with age.
Race
- Rapidly progressive glomerulonephritis is more prevalent in the white race more than the black race.
Gender
- Men and women are affected equally by rapidly progressive glomerulonephritis.
References
- ↑ Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.